Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness

被引:293
|
作者
Corrigan-Curay, Jacqueline [1 ]
Sacks, Leonard [1 ]
Woodcock, Janet [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 09期
关键词
TRIALS;
D O I
10.1001/jama.2018.10136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:867 / 868
页数:2
相关论文
共 50 条
  • [21] Uncertainties in real-world decisions on medical technologies
    Lu, C. Y.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (08) : 936 - 940
  • [22] Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world
    Uriarte-Pinto, Moises
    Navarro-Aznarez, Herminia
    De La Llama-Celis, Natalia
    Arazo-Garces, Piedad
    Maria Martinez-Sapina, Ana
    Reyes Abad-Sazatornil, Maria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 608 - 616
  • [23] Comparative effectiveness of treatments on time to remission in atopic dermatitis: real-world insights
    Sato, Emi
    Arima, Hisatomi
    Ito, Kotaro
    Iwata, Mayuko
    Imafuku, Shinichi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2024, 7
  • [24] Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data
    Landstedt-Hallin, Lena
    Gundgaard, Jens
    Ericsson, Asa
    Ellfors-Zetterlund, Susanne
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 647 - 655
  • [25] A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting
    Major-Pedersen, Atheline
    McCullen, Mary Kate
    Sabol, Mary Elizabeth
    Adetunji, Omolara
    Massaro, Joseph
    Neugut, Alfred I.
    Sosa, Julie Ann
    Hollenberg, Anthony N.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (01) : 9 - 16
  • [26] Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review
    Irving, Peter M.
    Hur, Peter
    Gautam, Raju
    Guo, Xiang
    Vermeire, Severine
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (09): : 1026 - 1040
  • [27] Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement
    Snyder, James M.
    Pawloski, Jacob A.
    Poisson, Laila M.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (05)
  • [28] HEALTH TECHNOLOGY PERFORMANCE ASSESSMENT: REAL-WORLD EVIDENCE FOR PUBLIC HEALTHCARE SUSTAINABILITY
    Guerra-Junior, Augusto Afonso
    Pires de Lemos, Livia Lovato
    Godman, Brian
    Bennie, Marion
    Serpa Osorio-de-Castro, Claudia Garcia
    Alvares, Juliana
    Heaney, Aine
    Vassallo, Carlos Alberto
    Wettermark, Bjorn
    Benguria-Arrate, Gaizka
    Gutierrez-Ibarluzea, Inaki
    Canuto Santos, Vania Cristina
    Petramale, Clarice Alegre
    Acurcio, Fransciso de Assis
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (02) : 279 - 287
  • [29] Use of real-world evidence for oncology clinical decision making in emerging economies
    Petracci, Fernando
    Ghai, Chirag
    Pangilinan, Andrew
    Suarez, Luis Alberto
    Uehara, Roberto
    Ghosn, Marwan
    FUTURE ONCOLOGY, 2021, 17 (22) : 2951 - 2960
  • [30] Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project
    Gallacher, John
    de Vulpillieres, Frederic de Reydet
    Amzal, Billy
    Angehrn, Zuzanna
    Bexelius, Christin
    Bintener, Christophe
    Bouvy, Jacoline C.
    Campo, Laura
    Diaz, Carlos
    Georges, Jean
    Gray, Alastair
    Hottgenroth, Antje
    Jonsson, Pall
    Mittelstadt, Brent
    Potashman, Michele H.
    Reed, Catherine
    Sudlow, Cathie
    Thompson, Robin
    Tockhorn-Heidenreich, Antje
    Turner, Andrew
    van der Lei, Johan
    Visser, Pieter Jelle
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (02) : 495 - 501